3 results
Approved WMOPending
The purpose of the current study is to determine the feasibility of using MFGS using Cetuximab-800CW as an intraoperative margin assessment tool for penile carcinoma.
Approved WMOCompleted
The main purpose of this pilot study is to investigate the feasibility of fluorescence imaging using cetuximab-IRDye800CW for intraoperative margin assessment in patients with cutaneous squamous cell carcinoma.
Approved WMORecruiting
The purpose of this study is to develop a new investigational procedure for diagnosing Barrett*s Esophagus (BE) and Esophageal Adenocarcinoma (EAC).